Australia markets closed

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
396.55-3.68 (-0.92%)
At close: 04:00PM EDT
396.25 -0.30 (-0.08%)
After hours: 05:52PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts21212625
Avg. Estimate4.044.116.6218.17
Low estimate3.613.7713.4314.58
High estimate4.444.518.2920.75
Year ago EPS3.053.8915.2316.62
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts21212928
Avg. Estimate2.58B2.65B10.71B11.72B
Low estimate2.44B2.6B10.6B10.98B
High estimate2.63B2.71B10.98B13.12B
Year ago sales2.34B2.49B9.87B10.71B
Sales growth (year/est)10.20%6.20%8.50%9.40%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS33.883.974.1
Actual EPS3.053.894.084.2
Difference0.050.010.110.1
Surprise %1.70%0.30%2.80%2.40%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate4.044.116.6218.17
7 days ago4.054.1316.7818.35
30 days ago4.024.116.718.3
60 days ago4.034.1216.5718.41
90 days ago4.054.1416.3617.97
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 days1N/AN/AN/A
Up last 30 days2111
Down last 7 daysN/AN/AN/AN/A
Down last 30 days2233
Growth estimatesVRTXIndustrySector(s)S&P 500
Current qtr.32.50%N/AN/AN/A
Next qtr.5.40%N/AN/AN/A
Current year9.10%N/AN/AN/A
Next year9.30%N/AN/AN/A
Next 5 years (per annum)12.97%N/AN/AN/A
Past 5 years (per annum)29.84%N/AN/AN/A